Abstract:Sir, We were presented with a baby born to a mother taking sodium valproate who wished to breast feed. There are no data on breast milk levels of sodium valproate; it is presumed from collateral evidence that some of the drug would pass across from maternal serum into the milk. Studies in animals given modest doses of sodium valproate during pregnancy (30-90 mg/kg) showed no significant teratogenic effects. When a much higher dose was used (about 600 mg/kg) there was a dose-related increase in the rate of intrauterine death and major fetal abnormalities, most of which involved the kidneys or the lower lumbar spine (Whittle, 1976). Information on the outcome of the pregnancies where sodium valproate has been taken as the main anticonvulsant is very scanty; in most reports two or more drugs have been used or, in the case of an abnormality, the family history has suggested a strong genetic element (W. Reckitt-Labaz, 1978, personal communication). Case 1, a 22-year-old primipara, was epileptic and changed to sodium valproate in November 1975. She was well controlled taking 1600 mg/day in divided doses. She had had irregular periods and did not realise that she was pregnant until she was about 14 weeks. She consequently booked at the hospital clinic at about 18 weeks. Her anticonvulsant drug was not changed. She was admitted in labour at term in July 1978 and delivered a healthy boy weighing 3010 g; Apgar score was 9 at one minute, and no abnormalities were observed. The baby breast fed well and was discharged home on the 6th day, slightly under his birthweight. Mother and baby were seen at 29 days after delivery. The baby was still breast feeding well, gaining weight, and beginning to smile. The sodium valproate level was measured in the mother's serum, as shown in the Figure. The level fell slightly at term without any change in the oral dose and then rose to the previous level by 29 days. The valproate level in the serum of the neonate was of the same order as that of the mother's at delivery, but fell to insignificant levels by 5 days and was undetectable at 29 days (Figure). The mean level of valproate in breast milk at 5 days was 50 mmol/l; it had fallen to 21 mmol/l by 29 days. The neonatal valproate level indicates that valproate crosses the placenta freely and maternal serum levels will reflect fetal serum levels. Sodium valproate crosses through from serum into breast milk and will be found at a level between 5 and 10% ofthat in the mother's serum. The absorption of valproate from breast milk by the neonate appears to be insignificant. In this instance there was no evidence of any abnormality associated with the use of this drug. It may be concluded that breast feeding while on theraneutic doses of sodium valproate is safe and will not Valproate

Epidemiology of Hamstring Tears in National Collegiate Athletic Association Athletes: Findings From the National Collegiate Athletic Association Injury Surveillance Program Between 2014/2015 and 2018/2019

Epidemiology of Injuries in National Collegiate Athletic Association Women's Basketball: 2014-2015 Through 2018-2019

Aripiprazole: pharmacology, efficacy, safety and tolerability

Epidemiology of Lateral Ligament Complex Tears of the Ankle in National Collegiate Athletic Association (NCAA) Sports: 2014-15 Through 2018-19

Epidemiology of Anterior Cruciate Ligament Tears in National Collegiate Athletic Association Athletes: 2014/2015-2018/2019

Epidemiology of Overuse and Acute Injuries Among Competitive Collegiate Athletes

Gynecomastia Associated with Enalapril and Diazepam

The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Girls' Basketball (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Women's Basketball (2004-2005 Through 2013-2014)

Chronic Pain of Osteoarthritis: Considerations for Selecting an Extended-Release Opioid Analgesic

Dire ted Markov point pro esses |

The development of a HAMstring InjuRy (HAMIR) index to mitigate injury risk through innovative imaging, biomechanics, and data analytics: protocol for an observational cohort study

Injuries sustained in National Collegiate Athletic Association men's and women's basketball, 2009/2010-2014/2015

Epidemiology of Sports Injuries Among High School Athletes in the United States: Data From 2015 to 2019

Catastrophic injuries and exertional medical events in lacrosse among youth, high school and collegiate athletes: longitudinal surveillance over four decades (1982–2020)

Injury and Illness in Elite Athletics: A Prospective Cohort Study Over Three Seasons

Epidemiology of Sports-Related Tendon Ruptures Presenting to Emergency Departments in the United States

Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure.

Body Checking Injuries in National Collegiate Athletic Association Men's Ice Hockey: Findings From the NCAA Injury Surveillance Program 2009/10 to 2019/20

Sodium valproate and pregnancy.

Epidemiology of injuries in U.S. high school track and field throwing events from 2008 to 2019

Methods to locate and track ion channels and receptors expressed in live neurons.